Hypha Labs (FUNI) Net Income towards Common Stockholders (2010 - 2026)
Hypha Labs' (FUNI) quarterly Net Income towards Common Stockholders came in at -$521114.0 in Q1 2026, up 18.81% YoY from -$438622.0 in Q1 2025, and little changed on a QoQ basis from -$521638.0 in Q4 2025.
Hypha Labs (FUNI) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Hypha Labs (FUNI) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$521114.0 in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 18.81% year-over-year to -$521114.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (down 9.17% YoY) and the FY2025 annual result came in at -$3.1 million, down 628.56% from the prior year.
- Net Income towards Common Stockholders steadied at -$521114.0 in Q1 2026, from -$521638.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $430338.0 in Q3 2023 to a low of -$1.3 million in Q4 2024.
- A 5-year average of -$210915.5 and a median of -$48307.0 in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders soared 623.17% — and 2024, when it plunged 557.8%.
- Tracing FUNI's Net Income towards Common Stockholders over 5 years: stood at -$240330.0 in 2022, then jumped by 221.76% to $292627.0 in 2023, then sank by 557.8% to -$1.3 million in 2024, then surged by 61.06% to -$521638.0 in 2025, then advanced by 0.1% to -$521114.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$521114.0 (Q1 2026), -$521638.0 (Q4 2025), and -$558415.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Hypha Labs | 1.48 Mn | 1.47 Mn | - | -304,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -304,757.00 |
| Mar 31, 2026 | -521,114.00 |
| Dec 31, 2025 | -521,638.00 |
| Sep 30, 2025 | -558,415.00 |
| Jun 30, 2025 | -562,023.00 |
| Mar 31, 2025 | -641,822.00 |
| Dec 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | 776,281.00 |
| Dec 31, 2023 | 137,750.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 527,829.00 |
| Mar 31, 2023 | 357,170.00 |
| Dec 31, 2022 | -240,330.00 |
| Sep 30, 2022 | -272,740.00 |
| Jun 30, 2022 | -266,370.00 |
| Mar 31, 2022 | -384,313.00 |
| Dec 31, 2021 | -469,757.00 |
| Sep 30, 2021 | -319,837.00 |
| Jun 30, 2021 | -177,214.00 |
| Mar 31, 2021 | 18,201.00 |